2016
DOI: 10.3109/08941939.2015.1119219
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacology of Ischemia–Reperfusion. Translational Research Considerations

Abstract: Ischemia-reperfusion (IRI) is a complex physiopathological mechanism involving a large number of metabolic processes that can eventually lead to cell apoptosis and ultimately tissue necrosis. Treatment approaches intended to reduce or palliate the effects of IRI are varied, and are aimed basically at: inhibiting cell apoptosis and the complement system in the inflammatory process deriving from IRI, modulating calcium levels, maintaining mitochondrial membrane integrity, reducing the oxidative effects of IRI an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
8
0
2

Year Published

2018
2018
2022
2022

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 14 publications
(10 citation statements)
references
References 110 publications
0
8
0
2
Order By: Relevance
“…The IPC is a phenomenon triggered by short episodes of ischemia and reperfusion before a long ischemia and reperfusion. The beneficial role of IPC is clearly evident from the literature, and it has been tested in different organs including intestine, brain, spinal cord, kidney, lung, liver, and human heart [19][20][21][22][23][24][25][26]. There are some studies explaining the changes in the neutrophil behavior after IPC.…”
Section: Introductionmentioning
confidence: 99%
“…The IPC is a phenomenon triggered by short episodes of ischemia and reperfusion before a long ischemia and reperfusion. The beneficial role of IPC is clearly evident from the literature, and it has been tested in different organs including intestine, brain, spinal cord, kidney, lung, liver, and human heart [19][20][21][22][23][24][25][26]. There are some studies explaining the changes in the neutrophil behavior after IPC.…”
Section: Introductionmentioning
confidence: 99%
“…These ROS cause cellular damage by attacking cellular membranes through the peroxidation of polyunsaturated fatty acids [ 6 ]. Several antioxidants have been found to be effective in the prevention of oxidative injury and inflammation in ovarian tissues exposed to I/R injury [ 7 ].…”
Section: Introductionmentioning
confidence: 99%
“…In animal models, xanthine oxidase may cause kidney fibrosis through inflammation, endothelial dysfunction, oxidative stress, and activation of the renin-angiotensin system [25]. In some studies, both allopurinol [26][27][28][29] and febuxosate [30][31][32][33][34] show renal protections independent from their UA lowering effect. Our present results did not support renal protection of the UA-lowering agents with statistical significance.…”
Section: Discussionmentioning
confidence: 99%